Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple cellular components via polyphenolic constituents refers to the broad, pleiotropic interactions of plant-derived polyphenols with various biological molecules. These compounds, including flavonoids, stilbenes, and phenolic acids, do not typically bind to a single high-affinity receptor but instead modulate a network of targets such as enzymes, transcription factors, and cell membranes (Fraga et al., 2019, PMID: 31467324). Their biological roles are primarily characterized by antioxidant, anti-inflammatory, and chemopreventive activities, often mediated through the activation of the Nrf2 pathway or the inhibition of NF-κB signaling (Hano & Tungmunnithum, 2020, PMID: 32234561). In disease contexts, they are studied for their potential in treating chronic conditions like cancer, cardiovascular disease, and neurodegeneration. However, their therapeutic application is often limited by poor pharmacokinetic properties, such as low systemic bioavailability and rapid metabolism. Furthermore, many polyphenols are classified as Pan-Assay Interference Compounds (PAINS) due to their non-specific binding and chemical reactivity, which can lead to false-positive results in drug discovery (Baell & Walters, 2014, PMID: 25244102). Despite these challenges, they remain a significant area of research for multi-target drug design and nutritional science.
Polyphenolic constituents exert their effects through multi-target interactions, including scavenging reactive oxygen species (ROS), inhibiting pro-inflammatory enzymes like COX-2 and LOX, modulating signaling pathways such as NF-κB and MAPK, and interacting directly with cell membrane lipids and various protein receptors (Fraga et al., 2019, PMID: 31467324; Hano & Tungmunnithum, 2020, PMID: 32234561).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple cellular components (via polyphenolic constituents).